1. Home
  2. CKX vs INTS Comparison

CKX vs INTS Comparison

Compare CKX & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

HOLD

Current Price

$10.75

Market Cap

22.1M

Sector

Energy

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$6.44

Market Cap

19.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CKX
INTS
Founded
1930
2012
Country
United States
United States
Employees
2
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
19.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CKX
INTS
Price
$10.75
$6.44
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$56.25
AVG Volume (30 Days)
1.5K
329.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
71.43
15.22
EPS
0.22
N/A
Revenue
$1,521,124.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.86
N/A
Revenue Growth
2.39
N/A
52 Week Low
$8.66
$0.19
52 Week High
$13.25
$8.06

Technical Indicators

Market Signals
Indicator
CKX
INTS
Relative Strength Index (RSI) 50.50 59.76
Support Level $10.25 $0.29
Resistance Level $11.20 $8.06
Average True Range (ATR) 0.56 0.49
MACD -0.03 -0.33
Stochastic Oscillator 15.73 18.25

Price Performance

Historical Comparison
CKX
INTS

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: